(Total Views: 472)
Posted On: 02/24/2020 6:07:17 AM
Post# of 154133
LOXO $234
https://seekingalpha.com/symbol/LOXO?s=loxo
Common side effects reported by patients receiving Vitrakvi in clinical trials include fatigue, nausea, cough, constipation, diarrhea, dizziness, vomiting, and increased AST and ALT enzyme blood levels in the liver. Health care providers are advised to monitor patient ALT and AST liver tests every two weeks during the first month of treatment, then monthly and as clinically indicated. Women who are pregnant or breastfeeding should not take Vitrakvi because it may cause harm to a developing fetus or newborn baby. Patients should report signs of neurologic reactions such as dizziness.
https://www.fda.gov/news-events/press-announc...type-tumor
https://seekingalpha.com/symbol/LOXO?s=loxo
Common side effects reported by patients receiving Vitrakvi in clinical trials include fatigue, nausea, cough, constipation, diarrhea, dizziness, vomiting, and increased AST and ALT enzyme blood levels in the liver. Health care providers are advised to monitor patient ALT and AST liver tests every two weeks during the first month of treatment, then monthly and as clinically indicated. Women who are pregnant or breastfeeding should not take Vitrakvi because it may cause harm to a developing fetus or newborn baby. Patients should report signs of neurologic reactions such as dizziness.
https://www.fda.gov/news-events/press-announc...type-tumor
(0)
(0)
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
